Concepedia

Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial

Dick de Zeeuw, Ronny Renfurm, George L. Bakris, Peter Rossing, Vlado Perkovic, Fan Fan Hou, Masaomi Nangaku, Kumar Sharma, Hiddo J.L. Heerspink, Alberto García-Hernández,

The Lancet Diabetes & Endocrinology · 2018 · 48 citations · 18 references

DOIFull text

Open access

Concepts

References

18

KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease

Paul E. Stevens, Sofia B. Ahmed, Juan Jesús Carrero et al. · Kidney International · 2024 · 7.4K citations · Full text

, , +17

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

Christoph Wanner, Silvio E. Inzucchi, John M. Lachin et al. · New England Journal of Medicine · 2016 · 3.6K citations · Full text

, , +17

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

American Journal of Kidney Diseases · 2012 · 1.3K citations

, , +10

An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function

Frank A. Holtkamp, Dick de Zeeuw, Merlin C. Thomas et al. · Kidney International · 2011 · 362 citations

, , +13

Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis

Chris J. Weston, Emma L. Shepherd, Lee C. Claridge et al. · Journal of Clinical Investigation · 2014 · 211 citations

, , +17